RELAPSED/REFRACTORY IMMUNE-MEDIATED KIDNEY DISEASE

Clinical trials for RELAPSED/REFRACTORY IMMUNE-MEDIATED KIDNEY DISEASE explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY IMMUNE-MEDIATED KIDNEY DISEASE trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY IMMUNE-MEDIATED KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Modified immune cells target Tough-to-Treat kidney disease

Disease control Recruiting now

This early-stage study is testing a new type of cell therapy called universal CAR-T cells (KN3601) in adults with severe autoimmune kidney diseases that have not responded to standard treatments. The main goals are to check if the treatment is safe and to see if it can help contr…

Matched conditions: RELAPSED/REFRACTORY IMMUNE-MEDIATED KIDNEY DISEASE

Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

RELAPSED/REFRACTORY IMMUNE-MEDIATED KIDNEY DISEASE

Get alerted when new RELAPSED/REFRACTORY IMMUNE-MEDIATED KIDNEY DISEASE trials appear

Modified immune cells target Tough-to-Treat kidney disease